# Galera Therapeutics (GRTX) Stock Price, News & Catalysts
Canonical URL: https://biopharmsignal.com/company/GRTX
## Company Profile
- Ticker: GRTX
- Exchange: NASDAQ
- Sector: Biopharma
- Location: United States
- Tags: Oncology
## Stock Data
- Close: 17.6 USD
- Market cap: Not available USD
- Last updated: 2026-07-10
## Business Overview
Galera Therapeutics was a biotech company focused on oncology supportive care and radiation-related therapies before its restructuring and decline. Its legacy was centered on protecting patients during cancer treatment.
## Why The Stock Is Moving

Current closing-price context is not available for GRTX.

## Geographic Base

Headquartered in the United States and listed on NASDAQ before restructuring, Galera sat in specialty oncology biotechnology.

## Business Model

The business depended on clinical development, regulatory steps, and the challenge of translating supportive-care science into a durable franchise.

## Landscape Position

Galera belongs to the historical oncology-biotech group rather than the current live public-company set.

## Future Catalysts

- Galera is now largely a legacy and closeout story, so the catalysts are corporate resolution rather than a fresh pipeline readout. The market is focused on what value remains after the prior oncology effort.

## Recent News
- 2026-04-14 18:08 EST — [Galera Therapeutics and Obsidian Therapeutics Announce Merger Agreement and $350 Million Concurrent Private Placement](https://biopharmsignal.com/news/GRTX/galera-therapeutics-and-obsidian-therapeutics-announce-merger-agreement-and-350--61b32647) — Source: Galera Therapeutics
- 2025-10-22 11:00 EST — [Galera Therapeutics Announces Acquisition of Dismutase Mimetics Portfolio by Toronto-based Biossil for up to $105 Million](https://biopharmsignal.com/news/GRTX/galera-therapeutics-announces-acquisition-of-dismutase-mimetics-portfolio-by-tor-3af0371d) — Source: Galera Therapeutics
- 2024-12-31 12:00 EST — [Galera Therapeutics completes acquisition of Nova Pharmaceuticals](https://biopharmsignal.com/news/GRTX/galera-therapeutics-completes-acquisition-of-nova-pharmaceuticals-e012e8fa) — Source: Galera Therapeutics
- 2024-08-14 11:00 EST — [Galera Announces Board Approval of Complete Liquidation and Dissolution](https://biopharmsignal.com/news/GRTX/galera-announces-board-approval-of-complete-liquidation-and-dissolution-64cc11a7) — Source: Galera Therapeutics
- 2024-05-13 11:00 EST — [Galera Reports First Quarter 2024 Financial Results and Recent Corporate Updates](https://biopharmsignal.com/news/GRTX/galera-reports-first-quarter-2024-financial-results-and-recent-corporate-updates-6f25c676) — Source: Galera Therapeutics